Concordance of Large Language Model Recommendations with Multidisciplinary Heart Team Decisions in Coronary

Armaun D Rouhi1, Shreyas V Menon2, Yazid K Ghanem3

  • 1Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

Insights

Large language models (LLMs) show potential as decision support tools for multidisciplinary heart teams (HTs), achieving 73% pooled agreement. However, LLM accuracy can be limited by outdated data and lack of transparency, requiring further prospective evaluation.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Decision Support

Background:

  • The multidisciplinary heart team (HT) is crucial for complex cardiovascular disease decisions.
  • Large language models (LLMs) are emerging as potential clinical decision support tools.
  • Evidence on LLM concordance with HT decisions is limited.

Purpose of the Study:

  • To synthesize evidence on LLM recommendations versus HT decisions.
  • To quantitatively estimate the agreement between LLMs and HTs.
  • To identify factors influencing LLM-HT concordance.

Main Methods:

  • A systematic literature search was conducted across PubMed, Scopus, and Web of Science.
  • Included studies evaluated LLM recommendations against multidisciplinary HT decisions (Nov 2022 - Feb 2026).
  • Random-effects meta-analysis was used to pool agreement proportions.

Main Results:

  • Four retrospective studies on coronary revascularization and aortic valve intervention were analyzed.
  • LLM-HT concordance ranged from 65-82% for coronary revascularization and 77% for aortic valve intervention.
  • Pooled agreement was 0.73 (95% CI 0.60-0.83), with substantial heterogeneity; discordance arose from outdated data and lack of transparency.

Conclusions:

  • LLMs show preliminary potential as adjunctive decision support for HTs.
  • Misclassifications can occur with complex patient factors and conflicting guidelines.
  • Further prospective studies across diverse LLMs are needed before clinical recommendation.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...